According to BB Biotech
's latest financial reports the company has $1.44 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2007-12-31 | $9.6 M | -4.15% |
2006-12-31 | $10.02 M | 1030.79% |
2005-12-31 | $0.88 M | -97.21% |
2004-12-31 | $31.78 M |